Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TERF1P2 Inhibitors

The term TERF1P2 Inhibitors represents a specialized class of chemical compounds designed to modulate the activity of TERF1P2, a molecular target currently under scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of TERF1P2 within cellular processes. The structural features of TERF1P2 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to refine their molecular configurations for precise binding to the target.

The significance of TERF1P2 Inhibitors lies in their potential to disrupt the biochemical activities associated with TERF1P2, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of TERF1P2 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of TERF1P2 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by TERF1P2 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding TERF1P2 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Sirolimus can inhibit mTOR, which is a key regulator of protein synthesis. This could indirectly lead to a reduction in the expression of various proteins, potentially including TERF1P2.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to heat shock protein 90 (Hsp90) and can interfere with its function, possibly affecting the stability and function of client proteins and their expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has been shown to affect various signaling pathways and may modulate gene expression, potentially impacting proteins such as TERF1P2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which might reduce the activity of downstream signaling pathways involved in protein synthesis, possibly affecting TERF1P2 expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of the MAP kinase pathway, which could lead to altered gene expression profiles, potentially reducing the expression of certain proteins.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, which may influence transcription factors and gene expression, potentially impacting protein levels, including TERF1P2.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor that could alter the expression of genes regulated by this pathway, potentially including TERF1P2.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

17-AAG is an Hsp90 inhibitor similar to Geldanamycin, which might affect the expression and stability of a range of proteins.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin interferes with protein synthesis at the level of peptide elongation, which could lead to reduced expression of many proteins.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 disrupts the interaction between p53 and MDM2, potentially enhancing p53 activity and affecting the expression of p53-regulated genes.